Clinical Trial Update: Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating pegylated interferon alfa-2b in combination with nucleos(t)ide analogues for chronic hepatitis B, with metabolic dysfun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• Nucleos(t)ide analogue(s)
• Pegylated Interferon Alpha-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: Shenzhen Third People's Hospital | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Chronic Hepatitis B | Phase 4 | Status: NOT_YET_RECRUITING